Background Major psychiatric disorders are growing public health concern that attributed
14% of the global burden of diseases. The management of major psychiatric disorders is …

Adherence to antipsychotics improves outcome in schizophrenia. There is a lack of
consensus on which factors most influence adherence behaviour and methodological …

Although non‐adherence is common across all branches of medicine, psychotic disorders
pose additional challenges that increase its risk. Despite the importance of non‐adherence …

Non-adherence is a major problem in the treatment of schizophrenia. Its high prevalence,
potentially severe consequences and associated costs make the study of this phenomenon …

Background: Medication adherence is critical to the effectiveness of psychopharmacologic
therapy. Psychiatric disorders present special adherence considerations, notably an altered …

Medication nonadherence is common among patients with schizophrenia and due to a
variety of factors including lack of insight, psychopathology, substance use disorder, issues …

BACKGROUND: The aim of this study was to assess the impact of a short message service
(SMS)-based strategy on adherence to antipsychotic treatment. METHODS: A multicentre …

Background Evidence from the global burden of diseases show that psychiatric disorders
are a growing public health concern. Maintaining adherence to medication is the most …

Background Mental disorders are characterized by a high likelihood of recurrence. Thus,
aftercare and follow-up interventions aim to maintain treatment gains and to prevent relapse …

Background Schizophrenia and bipolar disorder are characterized by a high disease
burden. Antipsychotic medication is an essential part of the treatment. However, non …